date,title,source
Nov-09-18,NASH clinical trial presentation and continued revenue growth,GlobeNewswire
Nov-19-18,"Immuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEO",GlobeNewswire
